sibrafiban

sibrafiban

Xubix Cardiology A 'superaspirin' GP IIb/IIIa receptor antagonist used to prevent post coronary-angioplasty coagulation
References in periodicals archive ?
Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes.
The oral glycoprotein inhibitor sibrafiban is no better than aspirin in secondary prevention of major ischemic events, even though it is the more potent inhibitor of platelet aggregation, reported Dr.